IBDEI25D ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36429,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Insufficiency
 ;;^UTILITY(U,$J,358.3,36429,1,4,0)
 ;;=4^I35.1
 ;;^UTILITY(U,$J,358.3,36429,2)
 ;;=^5007175
 ;;^UTILITY(U,$J,358.3,36430,0)
 ;;=I35.0^^137^1760^61
 ;;^UTILITY(U,$J,358.3,36430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36430,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis
 ;;^UTILITY(U,$J,358.3,36430,1,4,0)
 ;;=4^I35.0
 ;;^UTILITY(U,$J,358.3,36430,2)
 ;;=^5007174
 ;;^UTILITY(U,$J,358.3,36431,0)
 ;;=I35.2^^137^1760^62
 ;;^UTILITY(U,$J,358.3,36431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36431,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
 ;;^UTILITY(U,$J,358.3,36431,1,4,0)
 ;;=4^I35.2
 ;;^UTILITY(U,$J,358.3,36431,2)
 ;;=^5007176
 ;;^UTILITY(U,$J,358.3,36432,0)
 ;;=I35.9^^137^1760^58
 ;;^UTILITY(U,$J,358.3,36432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36432,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,36432,1,4,0)
 ;;=4^I35.9
 ;;^UTILITY(U,$J,358.3,36432,2)
 ;;=^5007178
 ;;^UTILITY(U,$J,358.3,36433,0)
 ;;=I21.4^^137^1760^57
 ;;^UTILITY(U,$J,358.3,36433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36433,1,3,0)
 ;;=3^NSTEMI Myocardial Infarction
 ;;^UTILITY(U,$J,358.3,36433,1,4,0)
 ;;=4^I21.4
 ;;^UTILITY(U,$J,358.3,36433,2)
 ;;=^5007088
 ;;^UTILITY(U,$J,358.3,36434,0)
 ;;=I42.8^^137^1760^46
 ;;^UTILITY(U,$J,358.3,36434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36434,1,3,0)
 ;;=3^Cardiomypathies NEC
 ;;^UTILITY(U,$J,358.3,36434,1,4,0)
 ;;=4^I42.8
 ;;^UTILITY(U,$J,358.3,36434,2)
 ;;=^5007199
 ;;^UTILITY(U,$J,358.3,36435,0)
 ;;=I20.8^^137^1760^7
 ;;^UTILITY(U,$J,358.3,36435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36435,1,3,0)
 ;;=3^Angina Pectoris NEC
 ;;^UTILITY(U,$J,358.3,36435,1,4,0)
 ;;=4^I20.8
 ;;^UTILITY(U,$J,358.3,36435,2)
 ;;=^5007078
 ;;^UTILITY(U,$J,358.3,36436,0)
 ;;=I42.2^^137^1760^56
 ;;^UTILITY(U,$J,358.3,36436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36436,1,3,0)
 ;;=3^Hypertrophic Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,36436,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,36436,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,36437,0)
 ;;=I35.8^^137^1760^59
 ;;^UTILITY(U,$J,358.3,36437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36437,1,3,0)
 ;;=3^Nonrheumatic Aortic Valve Disorders NEC
 ;;^UTILITY(U,$J,358.3,36437,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,36437,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,36438,0)
 ;;=I42.5^^137^1760^65
 ;;^UTILITY(U,$J,358.3,36438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36438,1,3,0)
 ;;=3^Restrictive Cardiomyopathy NEC
 ;;^UTILITY(U,$J,358.3,36438,1,4,0)
 ;;=4^I42.5
 ;;^UTILITY(U,$J,358.3,36438,2)
 ;;=^5007196
 ;;^UTILITY(U,$J,358.3,36439,0)
 ;;=I05.8^^137^1760^69
 ;;^UTILITY(U,$J,358.3,36439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36439,1,3,0)
 ;;=3^Rheumatic Mitral Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,36439,1,4,0)
 ;;=4^I05.8
 ;;^UTILITY(U,$J,358.3,36439,2)
 ;;=^5007043
 ;;^UTILITY(U,$J,358.3,36440,0)
 ;;=I08.8^^137^1760^70
 ;;^UTILITY(U,$J,358.3,36440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36440,1,3,0)
 ;;=3^Rheumatic Multiple Valve Diseases NEC
 ;;^UTILITY(U,$J,358.3,36440,1,4,0)
 ;;=4^I08.8
 ;;^UTILITY(U,$J,358.3,36440,2)
 ;;=^5007056
 ;;^UTILITY(U,$J,358.3,36441,0)
 ;;=I47.9^^137^1760^63
 ;;^UTILITY(U,$J,358.3,36441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36441,1,3,0)
 ;;=3^Paroxysmal Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,36441,1,4,0)
 ;;=4^I47.9
 ;;^UTILITY(U,$J,358.3,36441,2)
 ;;=^5007224
 ;;^UTILITY(U,$J,358.3,36442,0)
 ;;=I05.1^^137^1760^66
